Synonyms: AMG-162
Denosumab (anti-RANK ligand) (AMG-162) is a fully human monoclonal antibody that selectively inhibits primate RANKL. Denosumab inhibits the ability of human RANKL (143–317) to stimulate the formation of osteoclasts derived from murine RAW 264.7 cells with an IC50 value of 1.64 nM.
Shimon Sakaguchi
Nature Communications 2025;16, Article number:1325
David Baker
Dev Cell 2023;58(20):2163-2180.e9.
Michael Houghton
Cell Chem Biol 2020;27(7):780-792.e5
David Julius
Cell 2017;185-198.e16
Charles M. Rice
Cell 2018;172(3):423-438.e25
| Name | Citation | NF-κB | Others |
|---|---|---|---|
| QNZ (EVP4593) | 156 | TNF-α | |
| JSH-23 | 166 | ||
| CBL0137 Hydrochloride | 9 | FACT,p53 | |
| SC75741 | 53 | ||
| Curcumin | 50 | HDAC,Nrf2,p300 histone acetylatransferase | |
| Sodium 4-Aminosalicylate | 2 | ||
| Caffeic Acid Phenethyl Ester | 55 | ||
| Sodium salicylate | 1 | ||
| (-)-Parthenolide | 27 | p53,MDM2 ubiquitination,HDAC1 | |
| Andrographolide | 11 |
| Description |
Denosumab (anti-RANK ligand) (AMG-162) is a fully human monoclonal antibody that selectively inhibits primate RANKL. Denosumab inhibits the ability of human RANKL (143–317) to stimulate the formation of osteoclasts derived from murine RAW 264.7 cells with an IC50 value of 1.64 nM.
|
References |
|
|---|
| CAS No. | 615258-40-7 |
|---|---|
| Molecular Weight | 145.16 kDa |
| Isotype | human IgG1 |
| Source | HEK293 |
| Sterility | 0.2 μM filtered |
| Formulation | PBS Buffer, pH 7.4 |
| Storage | Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles. |
*Literature analysis of various clone (for this target) products available on the market shows that Sellecks selected clones are more frequently applied. (data until September 2024)
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.